Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs). Its product portfolio focuses on a range of therapeutic areas, including oncology, ophthalmology, neurology, psychology, cardiology, and more. Additionally, the company specializes in finished dosage forms manufacturing, chemical synthesis, genetic engineering, and other areas.